# YARTEMLEA

NDC: 62225-300
Generic name: narsoplimab
Labeler / Manufacturer: Omeros Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20260120

FDA application: BLA761152

## Active ingredients

- NARSOPLIMAB: 370 mg/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"62225-300"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=62225-300
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f8ff990a-0d2e-433f-9615-b9b097448991